KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address patients suffering from heart failure with ...
Levosimendan is an inotropic agent that has been shown in small studies to prevent or treat the low cardiac output syndrome after cardiac surgery. In a multicenter, randomized, placebo-controlled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback